Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Boehringer Ingelheim

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
50/100
Moderate Influence
$5.3M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
1
Revolving Door

Boehringer Ingelheim reported $5.3 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Justice
Office of the U.S. Trade Representative
Dept of the Interior
Small Business Administration
Federal Trade Commission
U.S. Senate

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecSquire Patton Boggs
PHAGOVHCR
1$349K
2024 Jul-SepMehlman Consulting
GOVPHA
1$344K
2024 Apr-JunK&L Gates
PHAGOVMED+1
1$271K
2024 Jan-MarVan Scoyoc Associates
HCRGOVMED+1
3$299K
2023 Oct-DecCornerstone Government Affairs
HCRGOV
3$326K
2023 Jul-SepSteptoe & Johnson
PHAGOV
4$300K
2023 Apr-JunTarplin, Downs & Young
GOVHCRMED
4$264K
2023 Jan-MarFierce Government Relations
HCRMEDGOV+1
2$267K

Boehringer Ingelheim Lobbying FAQ

Boehringer Ingelheim has spent $5.3M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Boehringer Ingelheim lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Boehringer Ingelheim has an Influence Score of 50/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Boehringer Ingelheim employs 4 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Boehringer Ingelheim has contacted 6 government entities as part of their lobbying activities, including Dept of Justice, Office of the U.S. Trade Representative, Dept of the Interior.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.